Tirzepatide FAQs

Who is a good candidate?

1

Tirzepatide may be appropriate for adults with BMI ≥30 or BMI ≥27 with weight-related medical conditions such as insulin resistance or metabolic syndrome. A medical evaluation is required to review medical history, medications, and metabolic risk factors before initiating treatment.

What is the difference between tirzepatide and semaglutide?

2

Tirzepatide activates two hormone pathways involved in metabolism (GLP-1 and GIP). This dual mechanism may produce greater appetite suppression and metabolic regulation when compared to Semaglutide.  

Is it FDA approved?

3

Yes. Tirzepatide is FDA-approved - common sold under the brand names Zepbound and Mounjaro.

How long does tirzepatide take for results to show?

4

Patients often notice appetite changes within the first two few weeks, with progressive weight loss occurring over several months. Similar to our Semaglutide Treatments, dosing is gradually increased in scheduled intervals to reach an effective therapeutic dose

How do I determine my dose?

5

Our Tirzepatide Treatment dosing is individualized and medically supervised. Treatment begins with a low starting dose, followed by gradual increases based on clinical response, weight loss progress, symptom management and overall metabolic health. Careful titration ensures treatment remains both effective and safe.

Will I need to take Tirzepatide indefinitely?

6

Tirzepatide is designed to support long-term metabolic health but does not have to be permanent for every patient. Many patients transition to lower maintenance doses or lifestyle-base maintenance only once goals are achieved. If discontinuation is appropriate, our providers will provide a structured-taper plan to help support long term weight stability.

How do I monitor my metabolic health?

7

Patients receive ongoing provider oversight throughout their treatment program. Monitoring may include regular weight and body composition tracking, symptom management, lifestyle habits, medication adjustments, and metabolic response. Rather than rapid weight loss alone, our Tirzepatide Treatments focus on long-term metabolic stability.

What should I expect as far as downtime

8

There is little to no procedural downtime. Patients receive once weekly subcutaneous injection.